Current filters:  
USA
Healthcare
United States
Sheppard Mullin Richter & Hampton
Thank you for listening and supporting this show over the past 49 episodes.
Duane Morris LLP
CMS indicated that if it concludes a hospital has failed to comply with the requirements, it may request a corrective action plan.
BakerHostetler
FDA Announces Proposed Information Collections – The Notice "announces the FDA information collection request from the OMB for a generic clearance
Dickinson Wright PLLC
You've probably heard that every provider's favorite laws, the Anti-Kickback Statute and its related, strict liability counterpart
Mintz
As we reported last week, the Centers for Medicare & Medicaid Services (CMS) recently released a proposed rule (the Medicare and Medicaid Programs:
Gibson, Dunn & Crutcher
On 30 January 2020, the Director-General of the World Health Organization declared that the outbreak of novel coronavirus (2019-nCoV) met the criteria for a Public Health Emergency of International
Reed Smith
The phrase may be biblical in origin, coming from the story of Cain and Abel, but its meaning certainly persists and has relevance today.
Mintz
Our Employment, Labor & Benefits colleagues recently blogged on the coronavirus and its ramifications for employers impacted by the outbreak.
Reed Smith
The novel coronavirus (2019-nCoV, also known as "SARS-CoV-2") has been declared a public health emergency (PHE) by the U.S. Department of Health and Human Services (HHS).
Dickinson Wright PLLC
Erica Erman is an attorney at Dickinson Wright PLLC, practicing health care law with a particular interest in behavioral health care and interactions between municipal law and health care law.
Singh & Associates
This section of the newsletter discusses recent drug approvals from U.S. Food and Drug Administration (USFDA) for various serious diseases.
Sheppard Mullin Richter & Hampton
The language of the FAR reflects an intent not to require "substantial transformation" for analysis under the FAR; "manufacture" does not require substantial transformation.
Reed Smith
Given the quantities of drugs that these programs purchase, and the age of the regulation, we'd call this a big deal.
Foley & Lardner
For the second year in a row, Foley & Lardner LLP and PYA hosted a compliance master class on various health-related compliance issues. "Let's Talk Compliance"
Sheppard Mullin Richter & Hampton
January 30th, 2020 marked a dramatic change in Medicaid funding, as the Trump Administration and Centers for Medicare & Medicaid Services ("CMS") showcased a plan...
Reed Smith
Mention the Third Restatement of Torts and the learned intermediary rule in the same sentence, and our response would be to cite §6(d) of the product liability part of the Restatement
Sheppard Mullin Richter & Hampton
Joining host Michael Cohen to explore the evolving regulations surrounding the food industry are two guests, Michael Roberts and Sascha Henry.
Seyfarth Shaw LLP
Recently, the Trump Administration issued its proposed Notice of Benefit & Payment Parameter for 2021 regulations.
McDermott Will & Emery
On October 11, 2017, the Alcohol and Tobacco Tax and Trade Bureau (TTB) reopened the comment period for the following three notices of proposed rulemaking
Holland & Knight
The CMS released a SMD letter and fact sheet on Jan. 30, 2020, that encouraged states to pursue block grant or per capita cap funding through their Medicaid programs as part of the new Healthy Adult Opportunity.
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Popular Contributors
Upcoming Events
Tools
Font Size:
Translation
Mondaq Social Media